Keywords: aclasta, effective, risedronate, study, published, april, issue

Aclasta more effective than risedronate

Article | 14 April 2009

Print This

A study published in the April 14 issue of The Lancet shows that a once-yearly infusion of Novartis' Aclasta (zoledronic acid) 5 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in